Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Gen Digital: A Cheap Stock With An Underappreciated Growth Opportunity (NASDAQ:GEN)

22 August 2026

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

22 August 2026

Singer Mari Wilson says famous beehive was not 'just what I always wanted' ahead of new album

22 August 2026

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

22 August 2026

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

22 August 2026
Facebook X (Twitter) Instagram
Business Saturday, Aug 22
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)
News

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk22 August 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

The Value Investor has a Master of Science with specialization in financial markets and a decade of experience tracking companies via catalytic company events. As the leader of the investing group Value In Corporate Events they provide members with opportunities to capitalize on IPOs, mergers & acquisitions, earnings reports and changes in corporate capital allocation. Coverage includes 10 major events a month with an eye towards finding the best opportunities. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Gen Digital: A Cheap Stock With An Underappreciated Growth Opportunity (NASDAQ:GEN)

Singer Mari Wilson says famous beehive was not 'just what I always wanted' ahead of new album

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

Drug kingpin jailed after fleeing to Dubai and five years on the run

Enovix Stock Is At The Lows For Good Reason (NASDAQ:ENVX)

Pony AI Inc. 2026 Q2 – Results – Earnings Call Presentation (NASDAQ:PONY) 2026-08-21

Editors Picks

Lyntris: Defense Play Does Not Appear To Be A Defensive Investment (Pending:LYNX)

22 August 2026

Singer Mari Wilson says famous beehive was not 'just what I always wanted' ahead of new album

22 August 2026

Aehr Test Systems: The FY2027 Rebound Is Real, But The Price Asks For Too Much (AEHR)

22 August 2026

Neurocrine Biosciences Stock: ‘House Full Of Options’ (NASDAQ:NBIX)

22 August 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

KORU Medical Systems Stock Selloff Offers An Opportunity (NASDAQ:KRMD)

22 August 2026

Eikon Therapeutics, Inc. (EIKN) Discusses Advances in PARP1 Biology and Next-Generation PARP Inhibitors in Oncology Transcript

22 August 2026

Drug kingpin jailed after fleeing to Dubai and five years on the run

22 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.